ARCHIVES

Anamorelin Increases Body Mass In Two Global Phase III Trials

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007

It’s Official: House Appropriations Committee Gives NCI $81 Million Increase OverPresident’s Request

September 23, 1983

HHS Carcinogen Guidelines Draft

June 13, 1980

HPV Vaccines Should Be Priority, Say President’s Cancer Panel

March 7, 2014

FDA Advisors Uphold Broad Mandate To Limit Use Of ESA Products In Cancer Indications.

May 11, 2007

ASRO President Tells Colleagues To Take Charge

October 26, 1990